IQVIA Announces Pricing of Senior Notes
Stocks in this Quantisnow insightHealth Care
Historical context for IQV
Across the 26 sessions after earlier IQV headlines, the stock closed higher 10 times and lower 16 times, with a median move of 1.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IQV | SPY |
|---|---|---|---|
| Jun 3, 2026 | IQVIA Announces Offering of Senior Notes | +0.8% | -0.7% |
| May 27, 2026 | IQVIA CEO to Speak at Jefferies Global Healthcare Conference | +2.2% | -0.0% |
| May 14, 2026 | IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities | -1.0% | +0.8% |
| May 8, 2026 | IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization | +0.0% | +0.8% |
| May 7, 2026 | IQVIA CFO to Speak at Bank of America Health Care Conference 2026 | +1.2% | -0.3% |
| May 5, 2026 | IQVIA Reports First-Quarter 2026 Results | +9.6% | +0.8% |
Quantisnow market dataNYSE
IQV
IQVIA Holdings Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Listed since
- 2013
Get push alerts for IQV
Full IQV profile on Quantisnow Follow IQV and get a push notification the moment its next story breaks.